| BlueBee. (3/6/19). "Press Release: BlueBee Achieves Health Data Hosting (HDS) Certification". Rijskwijk. |
2019-03-06 |
| Biper Therapeutics SAS. (2/14/23). "Press Release: Biper Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-Class Small Molecules to Treat Gastrointestinal Cancers". Strasbourg. |
2023-02-14 |
| Biotimus SAS. (2/20/24). "Press Release: Ex-Google DeepMind and Owkin Scientists Team up to Create Bioptimus to Build the First Universal AI Foundation Model for Biology". |
2024-02-20 |
| BioSerenity. (9/20/17). "Press Release: BioSerenity, Digital Health Champion, Raises 15 Million Euros". Paris. |
2017-09-20 |
| Biophytis S.A.. (7/8/19). "Press Release: Biophytis Announces the Launch of its Public Offering on Nasdaq". Paris & Cambridge, MA. |
2019-07-08 |
| Biophytis S.A.. (6/15/17). "Press Release: Biophytis Selects SGS Life Science Services to Conduct MACA-PK, Clinical Study of Macuneos in Dry AMD". Paris. |
2017-06-15 |
| Biophytis S.A.. (2/21/17). "Press Release: Biophytis Relocates to Pierre and Marie Curie University (UPMC) Campus and Solidifies Creation of Leading Translational Platform for Age-related Disease". Paris. |
2017-02-21 |
| Biophytis S.A.. (1/20/21). "Press Release: Biophytis Announces Public Filing of a Registration Statement for Proposed Initial Public Offering in the United States". Paris & Cambridge, MA. |
2021-01-20 |
| Biomunex Pharmaceuticals SASU. (2/7/22). "Press Release: Biomunex and Institut Curie Pursue Strategic Collaboration for Development of Disruptive Non-conventional T Cell Redirection Approach to Treating Cancer". Paris & Cambridge, MA. |
2022-02-07 |
| Biomunex Pharmaceuticals SASU. (2/16/21). "Press Release: Biomunex Pharmaceuticals Signs Strategic License and Co-Development Agreement with Onward Therapeutics for Proprietary Bispecific Antibody Program". Paris & Cambridge, MA. |
2021-02-16 |
| Biomunex Pharmaceuticals SASU. (1/15/19). "Press Release: Biomunex Pharmaceuticals Signs a Licensing Agreement with Sanofi for the Development of Bi- and Multi-specific Antibodies". Paris. |
2019-01-15 |
| bioMérieux S.A.. (8/30/17). "Press Release: First-Half 2017 Results". Marcy l’Étoile. |
2017-08-30 |
| bioMérieux S.A.. (7/20/17). "Press Release: Second-Quarter 2017 Business Review". |
2017-07-20 |
| bioMérieux S.A.. (7/18/18). "Press Release: Second-Quarter 2018 Business Review". |
2018-07-18 |
| bioMérieux S.A.. (6/6/19). "Press Release: bioMérieux Increases Its Holding in Hybiome from 54% to 67%". Marcy l’Étoile. |
2019-06-06 |
| bioMérieux S.A.. (5/31/18). "Press Release: bioMérieux Launches Endozyme II GO, an Innovative Test for the Detection of Endotoxins in Pharmaceutical Microbiology Control". Marcy l’Étoile. |
2018-05-31 |
| bioMérieux S.A.. (4/6/17). "Press Release: bioMérieux Receives FDA 510(k) Clearance for its BacT/Alert VIRTUO Fully Automated Blood Culture System". Marcy l’Étoile. |
2017-04-06 |
| bioMérieux S.A.. (4/4/18). "Press Release: bioMérieux Reinforces Its Offering of High Medical Value Immunoassay Biomarkers with the Acquisition of Astute Medical". Marcy l’Étoile. |
2018-04-04 |
| bioMérieux S.A.. (4/24/19). "Press Release: bioMérieux – First-Quarter 2019 Business Review". Marcy l’Étoile. |
2019-04-24 |
| bioMérieux S.A.. (4/20/17). "Press Release: The FilmArray Respiratory Panel 2 plus (RP2plus) Gets CE marked". Marcy l’Étoile. |
2017-04-20 |
| bioMérieux S.A.. (4/20/17). "Press Release: bioMérieux – First-Quarter 2017 Business Review". Marcy l’Étoile. |
2017-04-20 |
| bioMérieux S.A.. (4/19/18). "Press Release: bioMérieux – First-Quarter 2018 Business Review". |
2018-04-19 |
| bioMérieux S.A.. (4/15/19). "Press Release: “Global-PPS”, a Survey of Antibiotic Use and Bacterial Resistance in Hospitals Worldwide, Tops the 200,000 Patients". Marcy l’Étoile & Antwerp. |
2019-04-15 |
| bioMérieux S.A.. (4/14/23). "Press Release: Oxford Nanopore and bioMérieux to Enter into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics". Oxford & Marcy-l’Etoile. |
2023-04-14 |
| bioMérieux S.A.. (4/1/19). "Press Release: University of Antwerp, bioMérieux, and Wellcome Trust to Coordinate VALUE-Dx, a European Public-Private Partnership to Fight Antimicrobial Resistance through Diagnostics". Antwerp, London & Marcy l’Eoile. |
2019-04-14 |
| bioMérieux S.A.. (3/3/17). "Press Release: 2016 Financial Results". |
2017-03-03 |
| bioMérieux S.A.. (3/19/19). "Press Release: Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury". Deerfield, IL & Marcy l’Etoile. |
2019-03-19 |
| bioMérieux S.A.. (3/18/22). "Press Release: bioMérieux Receives FDA 510(k) Clearance for Its VITEK MS PRIME New MALDI-TOF Mass Spectrometry Identification System". Marcy l’Étoile. |
2022-03-18 |
| bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile. |
2019-02-07 |
| bioMérieux S.A.. (2/28/18). "Press Release: 2017 Financial Results". |
2018-02-28 |
| bioMérieux S.A.. (2/27/19). "Press Release: bioMérieux – 2018 Financial Results". |
2019-02-27 |
| bioMérieux S.A.. (2/24/17). "Press Release: bioMérieux’s VIDAS B•R•A•H•M•S PCT Becomes the First FDA-cleared Procalcitonin Assay as an Aid for Antibiotic Stewardship in Respiratory Infections and Sepsis". |
2017-02-24 |
| bioMérieux S.A.. (12/15/17). "Press Release: Alexandre Mérieux Appointed Chairman and CEO of bioMérieux". Marcy l’Étoile. |
2017-12-15 |
| bioMérieux S.A.. (11/9/18). "Press Release: bioMérieux Acquires a Majority Stake in Hybiome and Strengthens Its Presence Both in China and in the Immunoassay Market". Marcy l’Étoile. |
2018-11-09 |
| bioMérieux S.A.. (10/19/23). "Press Release: bioMérieux Makes Strategic Investment in Oxford Nanopore". Oxford & Marcy-l’Etoile. |
2023-10-19 |
| bioMérieux S.A.. (10/18/17). "Press Release: bioMérieux – Business Review for the Nine Months ended September 30, 2017". |
2017-10-18 |
| bioMérieux S.A.. (1/23/18). "Press Release: bioMérieux – Fourth-Quarter 2017 Business Review". |
2018-01-23 |
| bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux – Fourth-Quarter 2016 Business Review". Marcy l’Étoile. |
2017-01-19 |
| bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury". Marcy l’Étoile & San Diego, CA. |
2017-01-19 |
| bioMérieux S.A.. (1/15/18). "Press Release: CNES and bioMérieux Extend Their Collaboration on Aquapad, a Unique Water Quality Testing Tool". |
2018-01-15 |
| Biomemory SAS. (11/28/22). "Press Release: Biomemory Raises 5 Million Euros Seed Investment to Advance Its Cutting-edge DNA Digital Data Storage Solution". Paris. |
2022-11-28 |
| Biocorp. (5/29/17). "Press Release: Biocorp Signs an Industrialization Contract with Virbac". Issoire. |
2017-05-29 |
| Bico Group AB. (11/16/21). "Press Release: Cellenion Announces Co-marketing Agreement with Bruker to Deliver Advanced Solutions for Single Cell Mass Spectrometry-based Proteomics Analysis". |
2021-11-16 |
| Bico Group AB. (11/15/21). "Press Release: Cellenion Announces Co-marketing Agreement for Single Cell Mass Spectrometry-based Proteomics Analysis". |
2021-11-15 |
| Balmes Transplantation SAS. (2/6/18). "Press Release: Balmes Transplantation Raises €700,000 in Seed Funding". Marseille. |
2018-02-06 |
| AZMed SAS. (2/20/24). "Press Release: AZmed Secures €15 Million to Shape the Future of Medical Imaging with AI". Paris. |
2024-02-20 |
| AXA Investment Managers. (7/26/21). "Press Release: AXA IM Alts Raises €1.9 Billion for European Life Sciences Investments". |
2021-07-26 |
| AXA Investment Managers. (11/26/20). "Press Release: AXA Investment Managers - Real Assets to Enter European Life Science Sector with Acquisition of Kadans Science Partner Platform". |
2020-11-26 |
| Aurobac Therapeutics SAS. (10/4/22). "Press Release: Aurobac Therapeutics, the Joint Venture Recently Created by Boehringer Ingelheim, Evotec and bioMérieux, Appoints Florence Séjourné as Chief Executive Officer". Lyon. |
2022-10-04 |
| Astraveus SAS. (6/27/23). "Press Release: Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of Its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform". Paris. |
2023-06-27 |
| Asklepios BioPharmaceutical, Inc. (AskBio). (4/22/20). "Press Release: AskBio Acquires BrainVectis to Expand its Clinical Pipeline for Neurodegenerative Diseases". Research Triangle Park, NC & Paris. |
2020-04-22 |
| Arkhn SAS. (5/17/21). "Press Release: Arkhn Raises €4 Million to Lead Healthcare Institutions Towards Sovereign and Efficient Data Management". Paris. |
2021-05-17 |
| Argobio SAS. (9/25/23). "Press Release: Northern Gritstone and Argobio Studio Back Sheffield University Spin-out Crucible Therapeutics". Paris, Manchester & Sheffield. |
2023-09-25 |
| Argobio SAS. (3/2/21). "Press Release: Argobio Announces Its Launch with 50 M€ to Create and Develop Pioneering Biotech Spinouts with the Support of Bpifrance, Kurma Partners, Angelini Pharma, Evotec, and the Institut Pasteur". Paris. |
2021-03-02 |
| Argobio SAS. (2/8/22). "Press Release: Oncode Institute and ArgoBio Launch Laigo Bio, a Targeted Protein Degradation Biotech with Programs in Oncology and Neurological Disorders". Utrecht & Paris. |
2022-02-08 |
| Argobio SAS. (12/16/21). "Press Release: Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement". Paris & Tallinn. |
2021-12-16 |
| ArchiMed SAS. (8/5/21). "Press Release: ArchiMed Closes MED III at €650 Million Hard Cap in Less than Two Months". |
2021-08-05 |
| ArchiMed SAS. (11/3/21). "Press Release: ArchiMed Buys Cube, an Innovative Provider of Membrane Protein Services for the Biopharma Research Market". |
2021-11-03 |
| ArchiMed SAS. (10/7/22). "Press Release: ArchiMed Invests in PlasmidFactory, a German Gene and Cell Therapy Specialist". |
2022-10-07 |
| ArchiMed SAS. (10/5/21). "Press Release: ArchiMed Backs Xpress Biologics, a Leading Provider of Plasmid DNA for Advanced Therapy Medicinal Products". |
2021-10-05 |
| ArchiMed SAS. (1/12/21). "Press Release: ArchiMed Buys Germany’s Zyto Group of Cancer Diagnostics Companies in Partnership with Owners and Management". |
2021-01-12 |
| Arbiom Inc.. (12/14/17). "Press Release: Arbiom Led Consortium Receives €4M Refundable Loan from ADEME to Upscale Its Technology Allowing the Production of Sugars and Lignin from Forestry Material". Évry. |
2017-12-14 |
| Aqemia SAS. (6/15/22). "Press Release: Aqemia Announces an Extension of Its First Collaboration with Sanofi About AI and Quantum Physics-driven Drug Discovery in Oncology". Paris. |
2022-06-15 |
| Aqemia SAS. (2/14/22). "Press Release: Aqemia Announces Pilot Study with Janssen to Utilize Aqemia’s Physics-driven Drug Discovery Technology". Antwerp & Paris. |
2022-02-14 |
| Aqemia SAS. (12/5/23). "Press Release: Aqemia Announces a Major Multi-year Collaboration of $140 Million with Sanofi". Paris. |
2023-12-05 |
| Aqemia SAS. (12/16/21). "Press Release: Aqemia and Servier Announce AI and Quantum Physics-drive Drug Discovery Collaboration in Immuno-oncology". Paris. |
2021-12-16 |
| Aqemia SAS. (10/19/22). "Press Release: Aqemia Raises €30M to Scale its Deep Physics and AI Enabled Drug Discovery Pipeline". Paris. |
2022-10-19 |
| Aqemia SAS. (1/9/23). "Press Release: Servier and Aqemia Extend Collaboration on Undruggable Target in Immuno-Oncology". Paris. |
2023-01-09 |
| Aqemia SAS. (1/30/24). "Press Release: Aqemia Boosts Series A Funding to €60M to Accelerate on its Proprietary Therapeutic Pipeline". Paris. |
2024-01-30 |
| Apmonia Therapeutics SAS. (2/10/22). "Press Release: Apmonia Therapeutics Announces a 4 M€ Fundraising Round to Complete Regulatory Preclinical Studies of Its Anti-cancer Immunotherapy Drug Candidate (AP-01)". Reims. |
2022-02-10 |
| Apix Analytics S.A.. (12/1/17). "Press Release: Apix Analytics Raises 8 Million Euros to Accelerate Its International Development". Grenoble. |
2017-12-01 |
| Antabio SAS. (7/12/18). "Press Release: Antabio Completes € 12.5m Series A. New Investors Omnes, BNP Paribas Développement and Sham Innovation Santé Invest an Additional €5.2m". Labège. |
2018-07-12 |
| Antabio SAS. (12/12/23). "Press Release: Antabio Raises €25 Million in Series B Financing". Labège. |
2023-12-12 |
| Andera Partners. (7/7/22). "Press Release: Andera Partners Strengthens Its Life Sciences Team with a New Partner". |
2022-07-07 |
| Andera Partners. (4/4/18). "Press Release: EdRIP becomes Andera Partners. EdRIP Announced the Buyout of the Management Company by Its Employees, in Agreement with Its Majority Shareholder". Paris. |
2018-04-04 |
| Andera Partners. (4/27/21). "Press Release: Andera Partners Strengthens Its Presence in the DACH Region". |
2021-04-27 |
| Andera Partners. (2/16/23). "Press Release: Ahead of Its Business Plan, Andera Partners Approaches 4 Billion Euros in Assets Under Management and Announces a New 2028 Target of 6 to 8 Billion Euros". Paris. |
2023-02-16 |
| Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. |
2022-10-10 |
| Anagenesis Biotechnologies. (5/18/17). "Press Release: Anagenesis Biotechnologies Announces Strategic Research Agreement with Boehringer Ingelheim to Discover Drugs for Chronic Muscle Diseases". Illkirch Graffenstaden. |
2017-05-18 |
| Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. |
2018-12-04 |
| Amolyt Pharma SAS. (9/16/21). "Press Release: Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners". Lyon & Cambridge, MA. |
2021-09-16 |
| Amolyt Pharma SAS. (6/8/20). "Press Release: Amolyt Pharma Appoints Pierre Legault as a Director and Chairman of its Board of Directors as Company Transitions into Clinical Stage". Lyon & Newton, MA. |
2020-06-08 |
| Amolyt Pharma SAS. (6/2/20). "Press Release: Alizé Pharma 3 Announces Rebranding to Amolyt Pharma, Reflecting a Strategic Focus on Building and Advancing a Portfolio of Therapeutic Peptides for Rare Endocrine and Metabolic Diseases". Lyon & Newton, MA. |
2020-06-02 |
| Amolyt Pharma SAS. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA. |
2024-03-14 |
| Amolyt Pharma SAS. (2/4/22). "Press Release: Amolyt Pharma Selected for the French Tech 120 Program". Lyon & Cambridge, MA. |
2022-02-04 |
| Amolyt Pharma SAS. (12/8/20). "Press Release: Amolyt Pharma Announces Research Collaboration with PeptiDream". Lyon & Newton, MA. |
2020-12-08 |
| Amolyt Pharma SAS. (1/6/23). "Press Release: Amolyt Pharma Announces $138 Million Series C Financing led by Sofinnova Partners and co-led by Intermediate Capital Group". Lyon & Cambridge, MA. |
2023-01-06 |
| Amoéba S.A.. (8/19/19). "Press Release: Amoéba Informs that the EPA Cannot Grant the Registrations for the Use of Its Active Substance Willaertia magna C2c Maky in Cooling Towers". Lyon. |
2019-08-19 |
| Alma Bio Therapeutics S.A.S. (6/26/17). "Press Release: Alma Bio Therapeutics and Delphi Genetics Extend Strategic Alliance on Plasmid DNA Drugs". Lyon & Charleroi. |
2017-06-26 |
| Alizé Pharma. (7/31/19). "Press Release: Alizé Pharma 3 Raises €67 million ($75 million) in Series A from a Strong International Syndicate". Lyon. |
2019-07-31 |
| Alimera Sciences, Inc.. (8/29/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in France". Atlanta, GA. |
2017-08-29 |
| AlgoTherapeutix SAS. (9/1/22). "Press Release: AlgoTx Announces Initiation of Global Phase 2 Clinical Trial of ATX01 for the Relief of Pain in Chemotherapy-induced Peripheral Neuropathy in Adults". Suresnes. |
2022-09-01 |
| AlgoTherapeutix SAS. (3/14/23). "Press Release: AlgoTx Raises €20M to Conduct ATX01’s Phase 2 Program in Peripheral Neuropathic Pain". Suresnes. |
2023-03-14 |
| AlgoTherapeutix SAS. (11/24/20). "Press Release: AlgoTherapeutix Raises €12M to Take ATX01 into Clinical Development in Chemotherapy-induced Peripheral Neuropathy". Paris. |
2020-11-24 |
| Air Liquide Healthcare. (11/14/22). "Press Release: Air Liquide Healthcare Federates Its Biobanking Activity under the Name BioKryo and Inaugurates Its New Site in Germany". Bagneux. |
2022-11-14 |
| Aglaia Therapeutics. (9/27/21). "Press Release: New Startup Aglaia Therapeutics Raises €4M in Seed Funding to Overcome Resistance in Oncology Targeted Therapies". Villejuif. |
2021-09-27 |
| Agendia. (12/5/17). "Press Release: Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint BluePrint Breast Cancer Kit Co-Validation Study". Irvine, CA, Amsterdam & Paris. |
2017-12-05 |
| Afyren SAS. (8/26/21). "Press Release: Afyren, the Innovative Greentech for Sustainable Chemistry, Announces Its Planned IPO on Euronext Growth® in Paris [Not for US, CA, et al.]". Clermont-Ferrand. |
2021-08-26 |
| Affluent Medical S.A.. (1/29/24). "Press Release: Affluent Medical Closes €3.5 Million Bridge via Capital Iincrease from Key Shareholders [not for US, CA, AU, or JP]". Aix-en-Provence. |
2024-01-29 |
| Aelis Farma. (12/13/19). "Press Release: Aelis Farma Raises €11 Million to Accelerate the Clinical Development of a Paradigm-Shifting New Class of Drugs for Treating Cannabis Addiction and Cognitive Disorders". Bordeaux. |
2019-12-13 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 
Source
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
